BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14757851)

  • 1. Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism.
    Matias I; Chen J; De Petrocellis L; Bisogno T; Ligresti A; Fezza F; Krauss AH; Shi L; Protzman CE; Li C; Liang Y; Nieves AL; Kedzie KM; Burk RM; Di Marzo V; Woodward DF
    J Pharmacol Exp Ther; 2004 May; 309(2):745-57. PubMed ID: 14757851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostamides (prostaglandin-ethanolamides) and their pharmacology.
    Woodward DF; Liang Y; Krauss AH
    Br J Pharmacol; 2008 Feb; 153(3):410-9. PubMed ID: 17721551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
    Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
    Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
    Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
    Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.
    Francavilla F; Battista N; Barbonetti A; Vassallo MR; Rapino C; Antonangelo C; Pasquariello N; Catanzaro G; Barboni B; Maccarrone M
    Endocrinology; 2009 Oct; 150(10):4692-700. PubMed ID: 19608651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
    Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.
    Woodward DF; Krauss AH; Wang JW; Protzman CE; Nieves AL; Liang Y; Donde Y; Burk RM; Landsverk K; Struble C
    Br J Pharmacol; 2007 Feb; 150(3):342-52. PubMed ID: 17179945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
    Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
    Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
    Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
    Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
    Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
    Di Marzo V; Bisogno T; Sugiura T; Melck D; De Petrocellis L
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):15-9. PubMed ID: 9512456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
    Mulder AM; Cravatt BF
    Biochemistry; 2006 Sep; 45(38):11267-77. PubMed ID: 16981687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products.
    Woodward DF; Carling RW; Cornell CL; Fliri HG; Martos JL; Pettit SN; Liang Y; Wang JW
    Pharmacol Ther; 2008 Oct; 120(1):71-80. PubMed ID: 18700152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry.
    Weber A; Ni J; Ling KH; Acheampong A; Tang-Liu DD; Burk R; Cravatt BF; Woodward D
    J Lipid Res; 2004 Apr; 45(4):757-63. PubMed ID: 14729864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction.
    Maccarrone M; Barboni B; Paradisi A; Bernabò N; Gasperi V; Pistilli MG; Fezza F; Lucidi P; Mattioli M
    J Cell Sci; 2005 Oct; 118(Pt 19):4393-404. PubMed ID: 16144868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of intracellular carriers for the endocannabinoid anandamide.
    Kaczocha M; Glaser ST; Deutsch DG
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6375-80. PubMed ID: 19307565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.
    Hillard CJ; Shi L; Tuniki VR; Falck JR; Campbell WB
    J Mol Neurosci; 2007 Sep; 33(1):18-24. PubMed ID: 17901541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.